Old Web
English
Sign In
Acemap
>
authorDetail
>
Brian Burnette
Brian Burnette
Saint Vincent Hospital
Internal medicine
Medicine
Aromatase inhibitor
Breast cancer
Fulvestrant
3
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102
2018
Journal of Clinical Oncology
Noah Kornblum
Fengmin Zhao
Judith Manola
Paula Klein
Bhuvaneswari Ramaswamy
Adam Brufsky
P. J. Stella
Brian Burnette
Melinda L. Telli
Della F. Makower
Puneet S. Cheema
Cristina I. Truica
Antonio C. Wolff
Gamini S. Soori
Barbara B. Haley
Timothy R. Wassenaar
Lori J. Goldstein
Kathy D. Miller
Joseph A. Sparano
Show All
Source
Cite
Save
Citations (81)
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102
2018
Noah Kornblum
Fengmin Zhao
Judith Manola
Paula Klein
Bhuvaneswari Ramaswamy
Adam Brufsky
P. J. Stella
Brian Burnette
Melinda L. Telli
Della F. Makower
Puneet Cheema
Cristina I. Truica
Antonio C. Wolff
Gamini S. Soori
Barbara B. Haley
Timothy R. Wassenaar
Lori J. Goldstein
Kathy D. Miller
Joseph A. Sparano
Show All
Source
Cite
Save
Citations (0)
Post Transplant Lymphoproliferative Disorder in a Liver Transplant Patient with Refractory Crohnʼs Disease: 971
2009
The American Journal of Gastroenterology
John E. Eaton
Brian Burnette
John J. Poterucha
Show All
Source
Cite
Save
Citations (0)
1